Skip to main content
Journal ArticleOPEN ACCESS

Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma

Clinical Case Reports (2021) 9(4) 2264-2268
DOI: 10.1002/ccr3.4009
0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The development of resistance to trastuzumab in HER2-positive gastroesophageal cancer remains a problem. The use of dual HER2 blockade to overcome this is a therapeutic strategy that should be researched more extensively.

Author supplied keywords

Cite

CITATION STYLE

APA

Cheong, E. V., & Ho, G. F. (2021). Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma. Clinical Case Reports, 9(4), 2264–2268. https://doi.org/10.1002/ccr3.4009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free